MPL and myeloproliferative neoplasm: MPN patients negative for JAK2V617F may display mutations in the thrombopoietin receptor gene (MPL) [7] or the calreticulin gene (CALR) [8], which may also lead to dysregulated JAK/STAT-dependent processes.